PTC Therapeutics
PTCT
PTCT
174 hedge funds and large institutions have $2.21B invested in PTC Therapeutics in 2019 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 77 increasing their positions, 36 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
174
Holders Change
+10
Holders Change %
+6.1%
% of All Funds
3.77%
Holding in Top 10
7
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+16.67%
% of All Funds
0.15%
New
32
Increased
77
Reduced
36
Closed
22
Calls
$10M
Puts
$8.99M
Net Calls
+$1.05M
Net Calls Change
+$4.94M
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$54.2M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
+$53.4M |
| 3 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$40.9M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$29.1M |
| 5 |
RI
RTW Investments
New York
|
+$22.3M |
Top Sellers
| 1 |
BC
Boxer Capital
San Diego,
California
|
-$43.5M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$13.8M |
| 3 |
ACA
Avoro Capital Advisors
New York
|
-$13M |
| 4 |
PP
PDT Partners
New York
|
-$9.53M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$4.71M |
